Response Letter

Response Letter Breast Cancer Res Treat (2017) 165:469–470 DOI 10.1007/s10549-017-4352-z REBUTTAL LETTER Gail Lewis Phillips Received: 27 May 2017 / Accepted: 19 June 2017 / Published online: 30 June 2017 Springer Science+Business Media, LLC 2017 Dear Breast Cancer Research and Treatment Editors: brain microenvironment as a resistance mechanism to PI3K inhibitors in experimental brain lesions. Interestingly, it On behalf of my co-authors, we would like to thank Drs. was also demonstrated that Neuregulins, a family of HER3 Askoxylakis, Kodack, Ferraro, and Jain for their com- ligands, could desensitize tumor cells to PI3K inhibition, mentary on our recently published paper ‘‘Trastuzumab and this was reversed by co-treatment with a HER3 anti- Uptake and its Relation to Efficacy in an Animal Model of body or with pertuzumab, a HER2-HER3 dimerization HER2-Positive Breast Cancer Brain Metastasis (Breast inhibitor. The findings in this manuscript provide addi- Cancer Res Treat DOI: 10.1007/s10549-017-4279-4)’’. tional support for our hypothesis of differences in Briefly, our findings demonstrated uptake of labeled tras- microenvironment influencing response to targeted ther- tuzumab in intracranial brain grafts that was equivalent to apy, and confirm, in different mouse tumor models, our uptake in orthotopic (mammary fat pad, MFP) tumors, yet data showing enhanced efficacy with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Breast Cancer Research and Treatment Springer Journals

Loading next page...
 
/lp/springer_journal/response-letter-zOxGSLyjpy
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Oncology
ISSN
0167-6806
eISSN
1573-7217
D.O.I.
10.1007/s10549-017-4352-z
Publisher site
See Article on Publisher Site

Abstract

Breast Cancer Res Treat (2017) 165:469–470 DOI 10.1007/s10549-017-4352-z REBUTTAL LETTER Gail Lewis Phillips Received: 27 May 2017 / Accepted: 19 June 2017 / Published online: 30 June 2017 Springer Science+Business Media, LLC 2017 Dear Breast Cancer Research and Treatment Editors: brain microenvironment as a resistance mechanism to PI3K inhibitors in experimental brain lesions. Interestingly, it On behalf of my co-authors, we would like to thank Drs. was also demonstrated that Neuregulins, a family of HER3 Askoxylakis, Kodack, Ferraro, and Jain for their com- ligands, could desensitize tumor cells to PI3K inhibition, mentary on our recently published paper ‘‘Trastuzumab and this was reversed by co-treatment with a HER3 anti- Uptake and its Relation to Efficacy in an Animal Model of body or with pertuzumab, a HER2-HER3 dimerization HER2-Positive Breast Cancer Brain Metastasis (Breast inhibitor. The findings in this manuscript provide addi- Cancer Res Treat DOI: 10.1007/s10549-017-4279-4)’’. tional support for our hypothesis of differences in Briefly, our findings demonstrated uptake of labeled tras- microenvironment influencing response to targeted ther- tuzumab in intracranial brain grafts that was equivalent to apy, and confirm, in different mouse tumor models, our uptake in orthotopic (mammary fat pad, MFP) tumors, yet data showing enhanced efficacy with

Journal

Breast Cancer Research and TreatmentSpringer Journals

Published: Jun 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off